A blast from the past for long-timers here
PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes.
PhoreMost – the UK-based biopharmaceutical company dedicated to ‘drugging the undruggable’ – has announced a multi-project target discovery collaboration with Roche.
https://www.pharmatimes.com/news/phoremost_in_drug_target_discovery_collaboration_with_roche_1454612
And back in 2016
PhoreMost is using Phylogica's Phylomer library as a core element in its SITESEEKER phenotypic screening platform.
https://hotcopper.com.au/threads/how-bright-is-the-light-bulb.2937815/page-20?post_id=19890212
News: PYC Pyc Therapeutics Says FY Loss Attributable A$13.9 Million, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.015(1.16%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.28 | $2.464M | 1.904M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 5437 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 29562 | 3 |
View Market Depth
| Last trade - 11.59am 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |